Cargando…

Inhibiting Glycolysis and ATP Production Attenuates IL-33-Mediated Mast Cell Function and Peritonitis

Cellular metabolism and energy sensing pathways are closely linked to inflammation, but there is little understanding of how these pathways affect mast cell function. Mast cells are major effectors of allergy and asthma, and can be activated by the alarmin IL-33, which is linked to allergic disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Caslin, Heather L., Taruselli, Marcela T., Haque, Tamara, Pondicherry, Neha, Baldwin, Elizabeth A., Barnstein, Brian O., Ryan, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305324/
https://www.ncbi.nlm.nih.gov/pubmed/30619366
http://dx.doi.org/10.3389/fimmu.2018.03026
_version_ 1783382537587916800
author Caslin, Heather L.
Taruselli, Marcela T.
Haque, Tamara
Pondicherry, Neha
Baldwin, Elizabeth A.
Barnstein, Brian O.
Ryan, John J.
author_facet Caslin, Heather L.
Taruselli, Marcela T.
Haque, Tamara
Pondicherry, Neha
Baldwin, Elizabeth A.
Barnstein, Brian O.
Ryan, John J.
author_sort Caslin, Heather L.
collection PubMed
description Cellular metabolism and energy sensing pathways are closely linked to inflammation, but there is little understanding of how these pathways affect mast cell function. Mast cells are major effectors of allergy and asthma, and can be activated by the alarmin IL-33, which is linked to allergic disease. Therefore, we investigated the metabolic requirements for IL-33-induced mast cell function, to identify targets for controlling inflammation. We found that IL-33 increases glycolysis, glycolytic protein expression, and oxidative phosphorylation (OX PHOS). Inhibiting OX PHOS had little effect on cytokine production, but antagonizing glycolysis with 2-deoxyglucose or oxamate suppressed inflammatory cytokine production in vitro and in vivo. ATP reversed this suppression. Glycolytic blockade suppressed IL-33 signaling, including ERK phosphorylation, NFκB transcription, and ROS production in vitro, and suppressed IL-33-induced neutrophil recruitment in vivo. To test a clinically relevant way to modulate these pathways, we examined the effects of the FDA-approved drug metformin on IL-33 activation. Metformin activates AMPK, which suppresses glycolysis in immune cells. We found that metformin suppressed cytokine production in vitro and in vivo, effects that were reversed by ATP, mimicking the actions of the glycolytic inhibitors we tested. These data suggest that glycolytic ATP production is important for IL-33-induced mast cell activation, and that targeting this pathway may be useful in allergic disease.
format Online
Article
Text
id pubmed-6305324
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63053242019-01-07 Inhibiting Glycolysis and ATP Production Attenuates IL-33-Mediated Mast Cell Function and Peritonitis Caslin, Heather L. Taruselli, Marcela T. Haque, Tamara Pondicherry, Neha Baldwin, Elizabeth A. Barnstein, Brian O. Ryan, John J. Front Immunol Immunology Cellular metabolism and energy sensing pathways are closely linked to inflammation, but there is little understanding of how these pathways affect mast cell function. Mast cells are major effectors of allergy and asthma, and can be activated by the alarmin IL-33, which is linked to allergic disease. Therefore, we investigated the metabolic requirements for IL-33-induced mast cell function, to identify targets for controlling inflammation. We found that IL-33 increases glycolysis, glycolytic protein expression, and oxidative phosphorylation (OX PHOS). Inhibiting OX PHOS had little effect on cytokine production, but antagonizing glycolysis with 2-deoxyglucose or oxamate suppressed inflammatory cytokine production in vitro and in vivo. ATP reversed this suppression. Glycolytic blockade suppressed IL-33 signaling, including ERK phosphorylation, NFκB transcription, and ROS production in vitro, and suppressed IL-33-induced neutrophil recruitment in vivo. To test a clinically relevant way to modulate these pathways, we examined the effects of the FDA-approved drug metformin on IL-33 activation. Metformin activates AMPK, which suppresses glycolysis in immune cells. We found that metformin suppressed cytokine production in vitro and in vivo, effects that were reversed by ATP, mimicking the actions of the glycolytic inhibitors we tested. These data suggest that glycolytic ATP production is important for IL-33-induced mast cell activation, and that targeting this pathway may be useful in allergic disease. Frontiers Media S.A. 2018-12-18 /pmc/articles/PMC6305324/ /pubmed/30619366 http://dx.doi.org/10.3389/fimmu.2018.03026 Text en Copyright © 2018 Caslin, Taruselli, Haque, Pondicherry, Baldwin, Barnstein and Ryan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Caslin, Heather L.
Taruselli, Marcela T.
Haque, Tamara
Pondicherry, Neha
Baldwin, Elizabeth A.
Barnstein, Brian O.
Ryan, John J.
Inhibiting Glycolysis and ATP Production Attenuates IL-33-Mediated Mast Cell Function and Peritonitis
title Inhibiting Glycolysis and ATP Production Attenuates IL-33-Mediated Mast Cell Function and Peritonitis
title_full Inhibiting Glycolysis and ATP Production Attenuates IL-33-Mediated Mast Cell Function and Peritonitis
title_fullStr Inhibiting Glycolysis and ATP Production Attenuates IL-33-Mediated Mast Cell Function and Peritonitis
title_full_unstemmed Inhibiting Glycolysis and ATP Production Attenuates IL-33-Mediated Mast Cell Function and Peritonitis
title_short Inhibiting Glycolysis and ATP Production Attenuates IL-33-Mediated Mast Cell Function and Peritonitis
title_sort inhibiting glycolysis and atp production attenuates il-33-mediated mast cell function and peritonitis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305324/
https://www.ncbi.nlm.nih.gov/pubmed/30619366
http://dx.doi.org/10.3389/fimmu.2018.03026
work_keys_str_mv AT caslinheatherl inhibitingglycolysisandatpproductionattenuatesil33mediatedmastcellfunctionandperitonitis
AT tarusellimarcelat inhibitingglycolysisandatpproductionattenuatesil33mediatedmastcellfunctionandperitonitis
AT haquetamara inhibitingglycolysisandatpproductionattenuatesil33mediatedmastcellfunctionandperitonitis
AT pondicherryneha inhibitingglycolysisandatpproductionattenuatesil33mediatedmastcellfunctionandperitonitis
AT baldwinelizabetha inhibitingglycolysisandatpproductionattenuatesil33mediatedmastcellfunctionandperitonitis
AT barnsteinbriano inhibitingglycolysisandatpproductionattenuatesil33mediatedmastcellfunctionandperitonitis
AT ryanjohnj inhibitingglycolysisandatpproductionattenuatesil33mediatedmastcellfunctionandperitonitis